Fig. 1From: Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysisAntibiotic consumption in number of defined daily dose per inhabitants and per day and percentage pneumococcal conjugate vaccine (PCV) coverage. Squares are beta-lactams and macrolides consumption in the community (primary care sector) and dots are PCV coverage percent for primary immunisation at 24 months of age in France from 2000 to 2014Back to article page